Pérez V - Search Results

1

Neural correlates of impaired emotional discrimination in borderline personality disorder: an fMRI study.

Guitart-Masip M, Pascual JC, Carmona S, Hoekzema E, Bergé D, Pérez V, Soler J, Soliva JC, Rovira M, Bulbena A, Vilarroya O. Guitart-Masip M, et al. Among authors: perez v. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Nov 13;33(8):1537-45. doi: 10.1016/j.pnpbp.2009.08.022. Epub 2009 Sep 11. Prog Neuropsychopharmacol Biol Psychiatry. 2009. PMID: 19748540

2

A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.

Pérez V, Soler J, Puigdemont D, Alvarez E, Artigas F. Pérez V, et al. Arch Gen Psychiatry. 1999 Apr;56(4):375-9. doi: 10.1001/archpsyc.56.4.375. Arch Gen Psychiatry. 1999. PMID: 10197835 Clinical Trial.

3

[Olanzapine and cognitive-behavioural group therapy in borderline personality disorder].

Soler J, Campins MJ, Pérez V, Puigdemont D, Pérez-Blanco E, Alvarez E. Soler J, et al. Among authors: perez v, perez blanco e. Actas Esp Psiquiatr. 2001 Mar-Apr;29(2):85-90. Actas Esp Psiquiatr. 2001. PMID: 11333525 Spanish.

4

Ziprasidone in the acute treatment of borderline personality disorder in psychiatric emergency services.

Pascual JC, Oller S, Soler J, Barrachina J, Alvarez E, Pérez V. Pascual JC, et al. Among authors: perez v. J Clin Psychiatry. 2004 Sep;65(9):1281-2. doi: 10.4088/jcp.v65n0918b. J Clin Psychiatry. 2004. PMID: 15367057 Clinical Trial. No abstract available.

5

Double-blind, placebo-controlled study of dialectical behavior therapy plus olanzapine for borderline personality disorder.

Soler J, Pascual JC, Campins J, Barrachina J, Puigdemont D, Alvarez E, Pérez V. Soler J, et al. Among authors: perez v. Am J Psychiatry. 2005 Jun;162(6):1221-4. doi: 10.1176/appi.ajp.162.6.1221. Am J Psychiatry. 2005. PMID: 15930077 Clinical Trial.

6

SPECT of serotonin transporters using 123I-ADAM: optimal imaging time after bolus injection and long-term test-retest in healthy volunteers.

Catafau AM, Pérez V, Penengo MM, Bullich S, Danús M, Puigdemont D, Pascual JC, Corripio I, Llop J, Perich J, Alvarez E. Catafau AM, et al. Among authors: perez v. J Nucl Med. 2005 Aug;46(8):1301-9. J Nucl Med. 2005. PMID: 16085586 Free article.

7

Injectable atypical antipsychotics for agitation in borderline personality disorder.

Pascual JC, Madre M, Soler J, Barrachina J, Campins MJ, Alvarez E, Pérez V. Pascual JC, et al. Among authors: perez v. Pharmacopsychiatry. 2006 May;39(3):117-8. doi: 10.1055/s-2006-941489. Pharmacopsychiatry. 2006. PMID: 16721704

8

Failure to detect an association between the serotonin transporter gene and borderline personality disorder.

Pascual JC, Soler J, Barrachina J, Campins MJ, Alvarez E, Pérez V, Cortés A, Baiget M. Pascual JC, et al. Among authors: perez v. J Psychiatr Res. 2008 Jan;42(1):87-8. doi: 10.1016/j.jpsychires.2006.10.005. Epub 2006 Nov 29. J Psychiatr Res. 2008. PMID: 17137596 No abstract available.

9

Olanzapine orally-disintegrating tablet in severe psychotic agitation: a naturalistic study.

Pascual JC, Pérez V, Martín JL, Safont G, Puigdemont D, Alvarez E. Pascual JC, et al. Among authors: perez v. Actas Esp Psiquiatr. 2007 Jan-Feb;35(1):47-51. Actas Esp Psiquiatr. 2007. PMID: 17323225

10

The clinical global impression scale for borderline personality disorder patients (CGI-BPD): a scale sensible to detect changes.

Perez V, Barrachina J, Soler J, Pascual JC, Campins MJ, Puigdemont D, Alvarez E. Perez V, et al. Actas Esp Psiquiatr. 2007 Jul-Aug;35(4):229-35. Actas Esp Psiquiatr. 2007. PMID: 17592784

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,352 results

Search Page

Filters